title: Neuropathy as a potential complication of levodopa use in Parkinson's disease: a pharmacological and pharmacovigilance point of view.
authors.forename: Jean-Louis
authors.initials: JL
authors.lastname: Montastruc
authors.forename: Anne Charlotte
authors.initials: AC
authors.lastname: Danton
authors.forename: Genevieve
authors.initials: G
authors.lastname: Durrieu
authors.forename: Isabelle
authors.initials: I
authors.lastname: Lacroix
authors.forename: Pascale
authors.initials: P
authors.lastname: Olivier
authors.forename: Agnés
authors.initials: A
authors.lastname: Sommet
authors.forename: Jean-Michel
authors.initials: JM
authors.lastname: Senard
mesh_terms: D000978:Antiparkinson Agents / Q000009:adverse effects*; D016208:Databases, Factual / Q000706:statistics & numerical data; D006801:Humans; D007980:Levodopa / Q000009:adverse effects*; D010300:Parkinson Disease / Q000188:drug therapy; D011115:Polyneuropathies / Q000139:chemically induced*
chemical_list: D000978:Antiparkinson Agents; D007980:Levodopa